CSF3 and cancer: The relevance to further elucidate g-MDSC activity and the mechanism by which the combined use of G-CSF and Dex may selectively silence this activity bares important relevance to the use of checkpoint inhibitors as well as use of tumor-infiltrating lymphocytes (TILs) as novel forms of effective immunotherapy to treat cancer (30–32).